Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Bone Marrow Transplantation|March 7, 2003
Busulfan and cyclophosphamide as a preparative regimen for allogeneic blood and marrow transplantation in patients with non-Hodgkin's lymphomaT L Kiss, T Panzarella, H A Messner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Secondary malignancies after bone marrow transplantation in adultsR Lowsky, J Lipton, G Fyles, et al.
Cancer|February 1, 1990
Cutaneous and mucosal neoplasms in bone marrow transplant recipientsM Lishner, B Patterson, R Kandel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 7, 2000
Bone marrow mobilized with granulocyte colony-stimulating factor in related allogeneic transplant recipients: a study of 29 patientsS Couban, H A Messner, P Andreou, et al.
Current Oncology (Toronto, Ont.)|December 15, 2007
Integrating regional and community lung cancer services to improve patient careM Dahele, Y Ung, J Meharchand, et al.
Bone Marrow Transplantation|September 11, 1998
Safety of therapeutic anticoagulation in patients with multiple myeloma receiving autologous stem cell transplantationA D Schimmer, A K Stewart, A Keating, et al.
Bone Marrow Transplantation|November 18, 2000
Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin's lymphoma (NHL): results of a provincial strategy. Ontario BMT Network, CanadaA D Schimmer, S Jamal, H Messner, et al.
British Journal of Haematology|April 1, 1996
Peripheral blood progenitor cell collections in multiple myeloma: predictors and management of inadequate collectionsH M Prince, K Imrie, D R Sutherland, et al.
Bone Marrow Transplantation|February 26, 1999
The clinical utility of CMV surveillance cultures and antigenemia following bone marrow transplantationA Humar, K O'Rourke, J Lipton, et al.
Bone Marrow Transplantation|January 11, 2000
Intensification of the stem cell transplant induction regimen results in increased treatment-related mortality without improved outcome in multiple myelomaR Abraham, C Chen, R Tsang, et al.
Pageof 3